Panagora Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,282
Closed -$239K 1323
2023
Q2
$239K Buy
+12,282
New +$239K ﹤0.01% 1149
2022
Q4
Sell
-11,012
Closed -$291K 1521
2022
Q3
$291K Buy
11,012
+3,922
+55% +$104K ﹤0.01% 1284
2022
Q2
$315K Hold
7,090
﹤0.01% 1297
2022
Q1
$351K Hold
7,090
﹤0.01% 1322
2021
Q4
$361K Hold
7,090
﹤0.01% 1327
2021
Q3
$395K Sell
7,090
-8,932
-56% -$498K ﹤0.01% 1404
2021
Q2
$686K Buy
16,022
+15,733
+5,444% +$674K ﹤0.01% 1190
2021
Q1
$12K Sell
289
-13,736
-98% -$570K ﹤0.01% 2370
2020
Q4
$653K Hold
14,025
﹤0.01% 1132
2020
Q3
$596K Sell
14,025
-492
-3% -$20.9K ﹤0.01% 1096
2020
Q2
$697K Sell
14,517
-26,873
-65% -$1.29M ﹤0.01% 1071
2020
Q1
$1.9M Sell
41,390
-67,024
-62% -$3.08M 0.01% 606
2019
Q4
$6.51M Buy
108,414
+13,168
+14% +$791K 0.03% 421
2019
Q3
$5.39M Sell
95,246
-3,197
-3% -$181K 0.02% 442
2019
Q2
$5.48M Sell
98,443
-18,602
-16% -$1.04M 0.02% 472
2019
Q1
$5.91M Buy
117,045
+50,314
+75% +$2.54M 0.03% 465
2018
Q4
$2.69M Buy
66,731
+7,611
+13% +$307K 0.01% 665
2018
Q3
$4.1M Buy
59,120
+17,441
+42% +$1.21M 0.02% 581
2018
Q2
$3.15M Buy
+41,679
New +$3.15M 0.01% 707
2017
Q3
Sell
-70,806
Closed -$5.59M 2525
2017
Q2
$5.59M Buy
70,806
+14,240
+25% +$1.12M 0.02% 543
2017
Q1
$4.69M Sell
56,566
-1,195
-2% -$99.1K 0.02% 603
2016
Q4
$4.58M Buy
57,761
+704
+1% +$55.9K 0.02% 592
2016
Q3
$3.99M Sell
57,057
-22,483
-28% -$1.57M 0.02% 627
2016
Q2
$3.09M Buy
79,540
+3,038
+4% +$118K 0.02% 713
2016
Q1
$3.1M Buy
76,502
+41,901
+121% +$1.7M 0.02% 725
2015
Q4
$3.07M Buy
34,601
+7,760
+29% +$688K 0.02% 683
2015
Q3
$1.99M Buy
26,841
+4,578
+21% +$339K 0.01% 771
2015
Q2
$1.8M Buy
22,263
+10,164
+84% +$822K 0.01% 839
2015
Q1
$507K Buy
+12,099
New +$507K ﹤0.01% 1310